Efficacy and safety of co-trimoxazole in device-related bone and joint infections: a CRIOGO multicentre case-control study.
Raphaël LecomteColin DeschanvresAmandine Le BourgeoisGéraldine BartRafaël MahieuGwénaël Le MoalSéverine AnsartNathalie AsserayLouise Ruffier d'EpenouxStéphane CorvecDavid BoutoillePublished in: The Journal of antimicrobial chemotherapy (2024)
Co-trimoxazole appears to be an effective alternative for the treatment of BJI, even when it occurs on a device, but the safety profile requires close monitoring of adverse effects.